Germany: Seamless Therapeutics, a biotech company, has raised a US$12.5m in a seed financing round that will accelerate development of its designer recombinases, a novel gene editing platform to transform…
Germany: Seamless Therapeutics, a biotech company, has raised a US$12.5m in a seed financing round that will accelerate development of its designer recombinases, a novel gene editing platform to transform…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference